Pirfenidone Modified-Release Tablets

DRUG3 trials

Sponsors

Overseas Pharmaceuticals, Ltd.

Conditions

Idiopathic Pulmonary Fibrosis

Phase 1

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

CompletedNCT06569381

Overseas Pharmaceuticals, Ltd.Idiopathic Pulmonary Fibrosis

Start: 2024-09-18End: 2024-12-08Updated: 2025-03-20

Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

CompletedNCT06589921

Overseas Pharmaceuticals, Ltd.Idiopathic Pulmonary Fibrosis

Start: 2023-08-25End: 2023-09-14Updated: 2024-09-19

Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

CompletedNCT06588517

Overseas Pharmaceuticals, Ltd.Idiopathic Pulmonary Fibrosis

Start: 2024-04-08End: 2024-04-27Updated: 2024-09-19